Corebridge Financial’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,096	Closed	-$109K	–	2569
2025 Q1	$109K	Sell	12,096 -180	-1%	-$1.63K	﹤0.01%	2388
2024 Q4	$212K	Sell	12,276 -927	-7%	-$16K	﹤0.01%	2145
2024 Q3	$211K	Sell	13,203 -81	-0.6%	-$1.29K	﹤0.01%	2203
2024 Q2	$189K	Buy	+13,284	New	+$189K	﹤0.01%	2227